Cargando…

Compound Fuling Granule Suppresses Ovarian Cancer Development and Progression by disrupting mitochondrial function, galactose and fatty acid metabolism

Our previous studies have demonstrated that the compound fuling granule (CFG), a traditional Chinese medicine, suppresses ovarian cancer cell growth, migration and metastasis. However, the underlying mechanisms remain to be fully elucidated. In this study, we found that CFG could induce mitochondria...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ruan, Shanming, Zhang, Zhiqian, Tian, Xinxin, Huang, Dawei, Liu, Wenhong, Yang, Bo, Shen, Minhe, Tao, Fangfang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2018
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6160678/ https://www.ncbi.nlm.nih.gov/pubmed/30271500 http://dx.doi.org/10.7150/jca.25136

Ejemplares similares

Fuling Granule, a Traditional Chinese Medicine Compound, Suppresses Cell Proliferation and TGFβ-Induced EMT in Ovarian Cancer
por: Tao, Fangfang, et al.
Publicado: (2016)

PHD Finger Protein 19 Enhances the Resistance of Ovarian Cancer Cells to Compound Fuling Granule by Protecting Cell Growth, Invasion, Migration, and Stemness
por: Ruan, Shanming, et al.
Publicado: (2020)

Network Pharmacology, Molecular Docking, and Experimental Validation to Unveil the Molecular Targets and Mechanisms of Compound Fuling Granule to Treat Ovarian Cancer
por: Li, Zhaoyi, et al.
Publicado: (2022)

Retracted: Network Pharmacology, Molecular Docking, and Experimental Validation to Unveil the Molecular Targets and Mechanisms of Compound Fuling Granule to Treat Ovarian Cancer
por: Longevity, Oxidative Medicine and Cellular
Publicado: (2023)

Metabolomics Analysis for Defining Serum Biochemical Markers in Colorectal Cancer Patients with Qi Deficiency Syndrome or Yin Deficiency Syndrome
por: Tao, Fangfang, et al.
Publicado: (2017)

Regulation of hPCL3 isoforms’ ubiquitination by TRIM21 in non-small cell lung cancer progression
por: Xu, Ye, et al.
Publicado: (2023)

HIT000218960 promotes gastric cancer cell proliferation and migration through upregulation of HMGA2 expression
por: Sun, Leitao, et al.
Publicado: (2019)

What is the correct scientific name for “Fuling” medicinal mushroom?
por: Papp, Viktor, et al.
Publicado: (2022)

The Multiple Pharmacologic Functions and Mechanisms of Action of Guizhi Fuling Formulation
por: Gao, Jie, et al.
Publicado: (2022)

The Role of Combination Maintenance with Pemetrexed and Bevacizumab for Advanced Stage Nonsquamous Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis
por: Shan, Feiyu, et al.
Publicado: (2018)

Risk of Second Primary Malignancies in Colon Cancer Patients Treated With Colectomy
por: Zhang, Bo, et al.
Publicado: (2020)

Resveratrol inhibits the invasion and metastasis of colon cancer through reversal of epithelial- mesenchymal transition via the AKT/GSK-3β/Snail signaling pathway
por: Yuan, Li, et al.
Publicado: (2019)

Resveratrol inhibits the invasion and metastasis of colon cancer through reversal of epithelial-mesenchymal transition via the AKT/GSK-3β/Snail signaling pathway
por: Yuan, Li, et al.
Publicado: (2022)

Guizhi Fuling Capsule Exhibits Antidysmenorrhea Activity by Inhibition of Cyclooxygenase Activity
por: Zheng, Weiran, et al.
Publicado: (2020)

Metabolomics Study of Guizhi Fuling Capsules in Rats With Cold Coagulation Dysmenorrhea
por: Zhang, Yu, et al.
Publicado: (2021)

Traditional Chinese medicine prescription Guizhi Fuling Pills in the treatment of endometriosis
por: Wang, Xin, et al.
Publicado: (2021)

The Method of Activating Blood and Dredging Collaterals for Reducing Chemotherapy-Induced Peripheral Neuropathy: A Systematic Review and Meta-Analysis
por: Li, Zhaoyi, et al.
Publicado: (2019)

Expression of Protein 4.1 Family in Breast Cancer: Database Mining for 4.1 Family Members in Malignancies
por: Feng, Guan, et al.
Publicado: (2019)

Risk factors and predictors of lymph nodes metastasis and distant metastasis in newly diagnosed T1 colorectal cancer
por: Guo, Kaibo, et al.
Publicado: (2020)

Resveratrol and Its Analogs: Potent Agents to Reverse Epithelial-to-Mesenchymal Transition in Tumors
por: Guo, Kaibo, et al.
Publicado: (2021)

CXCR4 and CXCR3 are two distinct prognostic biomarkers in breast cancer: Database mining for CXCR family members
por: Guo, Kaibo, et al.
Publicado: (2019)

Results from a Meta-analysis of Combination of PD-1/PD-L1 and CTLA-4 Inhibitors in Malignant Cancer Patients: Does PD-L1 Matter?
por: Feng, Yuqian, et al.
Publicado: (2021)

Association of Survival and Immune-Related Adverse Events With Anti-PD-1/PD-L1 and Anti-CTLA-4 Inhibitors, Alone or Their Combination for the Treatment of Cancer: A Systematic Review and Meta-Analysis of 13 Clinical Trials
por: Zhang, Leyin, et al.
Publicado: (2021)

Identification of biomarkers in colon cancer based on bioinformatic analysis
por: Zhu, Ying, et al.
Publicado: (2020)

The Effects of Guizhi Fuling Capsule Drug Serum on Uterine Leiomyoma Cells and Its Mechanism
por: Shen, Qi, et al.
Publicado: (2016)

Deciphering the Pharmacological Mechanisms of Guizhi-Fuling Capsule on Primary Dysmenorrhea Through Network Pharmacology
por: Zhang, Siqin, et al.
Publicado: (2021)

Efficacy of Guizhi Fuling Wan for primary dysmenorrhea: protocol for a randomized controlled trial
por: Du, Yun, et al.
Publicado: (2021)

Overcoming cisplatin resistance by targeting the MTDH-PTEN interaction in ovarian cancer with sera derived from rats exposed to Guizhi Fuling wan extract
por: Han, Li, et al.
Publicado: (2020)

Stress granules inhibit fatty acid oxidation by modulating mitochondrial permeability
por: Amen, Triana, et al.
Publicado: (2021)

A network pharmacology approach to investigate the pharmacological effects of Guizhi Fuling Wan on uterine fibroids
por: Zeng, Liuting, et al.
Publicado: (2017)

The Genus Pachyma (Syn. Wolfiporia) Reinstated and Species Clarification of the Cultivated Medicinal Mushroom “Fuling” in China
por: Wu, Fang, et al.
Publicado: (2020)

Integrating Network Pharmacology and Experimental Validation Deciphers the Mechanism of Guizhi Fuling Wan against Adenomyosis
por: Wang, Haoxian, et al.
Publicado: (2021)

Correction to: Efficacy of Guizhi Fuling Wan for primary dysmenorrhea: protocol for a randomized controlled trial
por: Du, Yun, et al.
Publicado: (2021)

PB2076: GUIZHI FULING CAPSULE REGULATES AUTOPHAGY TO INTERFERE WITH BORTEZOMIB-INDUCED PERIPHERAL NEUROPATHY
por: Fu, Jiaqi, et al.
Publicado: (2023)

Association between the overexpression of Her3 and clinical pathology and prognosis of colorectal cancer: A meta-analysis
por: Yan, Qingying, et al.
Publicado: (2018)

Jiedu Sangen Decoction Inhibits the Invasion and Metastasis of Colorectal Cancer Cells by Regulating EMT through the Hippo Signaling Pathway
por: Yuan, Li, et al.
Publicado: (2019)

Inhibition to Epithelial-Mesenchymal Transition and Metastatic Potential In Colorectal Cancer Cell By Combination of Traditional Chinese Medicine Formulation Jiedu Sangen Decoction and PD-L1 Inhibitor
por: Shan, Feiyu, et al.
Publicado: (2020)

Nrf2 Signaling Pathway Mediates the Protective Effects of Daphnetin Against D-Galactose Induced-Premature Ovarian Failure
por: Zhang, Mengwen, et al.
Publicado: (2022)

Integrated identification, qualification and quantification strategy for pharmacokinetic profile study of Guizhi Fuling capsule in healthy volunteers
por: Zhong, Yun-Xi, et al.
Publicado: (2016)

Add-on effect of Guizhi Fuling formula to mifepristone for endometriosis: A meta-analysis of randomized controlled trials
por: Meng, Wenbin, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_096jija1q6guaarvqdbaft49ci